Trials / Completed
CompletedNCT03535077
Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)
Assessing Tissue Remodeling in the Skin Using Skin Fluorescence Imaging (SFI)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 186 (actual)
- Sponsor
- Orlucent, Inc · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The goal of the SFI is to provide non-invasive information about tissue remodeling occurring during melanocytic transition and atypia development in the skin
Detailed description
The goal of the SFI is to provide non-invasive information about tissue remodeling occurring during melanocytic transition and atypia development in the skin. SFI analyzes the topical staining of the skin surface using the ORL-1 dye to reveal the presence of remodeling in the skin, together with the visible feature characteristics. The system provides a biometric score corresponding to the dye staining, a structural score, and a composite SFI score to quantify the presence of tissue remodeling and the process of melanocytic transition in the skin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Diagnostic Test | Imaging of the suspicious lesion after application of ORL-1 dye prior to biopsy |
Timeline
- Start date
- 2018-01-24
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2018-05-24
- Last updated
- 2024-01-10
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03535077. Inclusion in this directory is not an endorsement.